Mesoblast Investor

Mesoblast is a medicine company that develops biologic products for the broad field of regenerative medicine.

Total Funding: 227295275 USD
Headquarters: Australia
Funding Status: IPO
Employee Number: 51-100
Estimated Revenue: $10M to $50M
Investment Stage: N/A
Last Funding Type: Post-IPO Equity
Number Of Exists: 1
Technology: diagnostics
Investor Type: N/A
Last Funding Date: 2020-05-13
Investors Number: 2
Founded Date: 2004-01-01
Industry: Biotechnology, Health Care, Science and Engineering